DPM-1001

DB18390ExperimentalSmall molecule

DPM-1001: Overview.

Mechanism: Pharmacologically active on Tyrosine-protein phosphatase non-receptor type 1
Curator reviewed
Formula / weight: C₃₅H₅₇N₃O₃ · 567.859 g/mol (avg)
Also known as: Cholan-24-oic acid, 7-hydroxy-3-[[4-[(2-pyridinylmethyl)amino]butyl]amino]-, methyl ester, (3β,5α,7α)- · Methyl (3β,5α,7α)-7-hydroxy-3-[[4-[(2-pyridinylmethyl)amino]butyl]amino]cholan-24-oate · methyl (R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-2-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Code names: DPM-1001

Resolves to

Compound

Structure

[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCCNCC1=CC=CC=N1)[C@H](C)CCC(=O)OC

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with DPM-1001, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.